AI Visibility Scorecard
stellarnetstudy.com · Healthcare
At 2.47/10, STELLAR-311 Clinical Trial (Exelixis) is near-invisible in AI search today. Most AI engines will not name it when asked about its category. The weakest signals are Structured Data, Backlinks and Domain Authority. That is fixable, and the signals below show where to start.
AI engines read this profile 6 times
Claude · Amazon Alexa · Parallel · Perplexity
Top 50% in Healthcare for AI visibility
19
AI Naming Predictability
iRarely named · 19/100
Healthcare average 11
Top 19% of Healthcare
See what's behind this score →2.47
-
Network Authority
iNot connected yet
0 relationships on record. Businesses in Healthcare average 3. Claim your page and Engagemii is your first.
See what's behind this score →5
0
from our crawl and measurement
STELLAR-311 Clinical Trial (Exelixis) describes itself simply: "Learn more about STELLAR-311, a new study for people living with advanced or metastatic neuroendocrine tumors. Zanzalintinib has not been approved by Regulatory Authorities." When AI engines look at it, they find little to work with. It scores 2.47 out of 10.
Our crawl found a sitemap and a readable heading structure. It is missing structured data describing the business and an llms.txt file.
AI crawlers have read this profile 6 times in our tracking, including ClaudeBot (Anthropic), AmazonBot (Alexa AI) and ShapBot (Parallel).
Strong · Good · Fair · Weak
Structured Data
Weak
Organization / LocalBusiness JSON-LD that AI can read.
Content Structure
Strong
Clear headings and answer-style content.
Entity Clarity
Strong
How clearly your brand identity reads to AI.
E-E-A-T Signals
Experience, Expertise, Authority, Trust
Fair
Experience, Expertise, Authority, Trust markers.
Technical AEO
Good
robots.txt, llms.txt, and AI-bot crawl access.
AI Discoverability
Good
Sitemaps and entity links AI can follow.
How the web signals your brand to AI
Backlinks
Weak
No inbound links found yet.
Domain Authority
Weak
Little domain authority yet.
Reference Presence
-
Not yet measured.
News & Press
Weak
No press coverage found yet.
Community
Weak
No community discussion yet.
Social Mentions
Weak
No social discussion found yet.
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can read your site and name it in answers. At 2.47/10, STELLAR-311 Clinical Trial (Exelixis) is near-invisible to AI engines today. That is fixable, and the signals above are where to start.
Is There a Clinical Study Site Near Me?
STELLAR-311 will take place in the U.S. and abroad. For specific location and site information, and to confirm whether sites near you are still enrolling new participants, call 1-888-393-5494 (toll-free) or 1-303-389-1847, or email [email protected] with currently open or planned study sites:United StatesPuerto RicoCanadaFranceItalyNetherlandsPolandSouth KoreaEnglandStudy sites may start or stop enrolling.
ChatGPT doesn't crawl the web like Google does. When someone asks Claude about the best project management tools, the model isn't searching your website in real-time. It's pulling from training data that stopped months or years ago.
Continue reading in your free Engagemii portalSign up free to read the full article and get your AEO fix list for STELLAR-311 Clinical Trial (Exelixis).
Scored by Engagemii on November 9, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/stellarnetstudy
Cite this score: Engagemii (2026). "AEO Score for STELLAR-311 Clinical Trial (Exelixis)." Retrieved from https://engagemii.com/aeo/brands/stellarnetstudy
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform